Biological characterization and stability of three lytic wastewater-derived bacteriophages targeting

Martyna Cieślik1, Olaf Bajrak1, Michał Wójcicki1

  • 1Bacteriophage Laboratory, Department of Phage Therapy, Hirszfeld Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Wrocław, Poland.

Microbiological Research
|August 27, 2025
PubMed

Insights

Novel bacteriophages targeting multidrug-resistant Acinetobacter baumannii and Acinetobacter johnsonii were isolated and characterized. These strictly lytic phages show potential as alternative antimicrobial agents against challenging bacterial infections.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Biotechnology

Background:

  • Rising antimicrobial resistance necessitates novel therapeutic strategies.
  • Acinetobacter baumannii and Acinetobacter johnsonii are significant multidrug-resistant pathogens.
  • Bacteriophage therapy offers a promising alternative to conventional antibiotics.

Purpose of the Study:

  • To isolate and comprehensively characterize novel Acinetobacter-specific bacteriophages.
  • To evaluate the potential of these bacteriophages as therapeutic agents against multidrug-resistant Acinetobacter species.
  • To assess the stability and suitability of phage preparations for therapeutic applications.

Main Methods:

  • Isolation of bacteriophages from sewage samples.
  • Genomic analysis to determine phage type (lytic vs. temperate).
  • Characterization of phage lytic activity, host range, adsorption, infection kinetics, and stability under various conditions (pH, temperature, cryoprotectants, storage materials).

Main Results:

  • Three novel, strictly lytic Acinetobacter-specific bacteriophages (Acba_19, Acjo_20, Acba_21) were identified.
  • Detailed characterization of their biological and physicochemical properties was performed.
  • Stability studies indicated suitability for potential therapeutic formulation.

Conclusions:

  • The characterized bacteriophages represent a potential new tool for combating multidrug-resistant Acinetobacter infections.
  • Further research into their efficacy and safety in clinical settings is warranted.
  • These findings contribute to the advancement of phage therapy as an alternative antimicrobial approach.